BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| oligosaccharides {oligosaccharides} - Rikenellaceae |
👶
High purity galacto-oligosaccharides enhance specific Bifidobacterium species and their metabolic activity in the mouse gut microbiome. Beneficial microbes (Benef Microbes ) Vol: 7 Issue 2 Pages: 247-64 Pub: 2016 Epub: 2016 Feb 3 Authors Monteagudo-Mera A , Arthur JC , Jobin C , Keku T , Bruno-Barcena JM , Azcarate-Peril MA , Html Article Publication |
| oligosaccharides {oligosaccharides} - Rikenellaceae |
📓
Effects of xylo-oligosaccharide supplementation on the production performance, intestinal morphology, cecal short-chain fatty acid levels, and gut microbiota of laying hens. Poultry science (Poult Sci ) Vol: 103 Issue 12 Pages: 104371 Pub: 2024 Dec Epub: 2024 Sep 30 Authors Xiong S , Zhang K , Wang J , Bai S , Zeng Q , Liu Y , Peng H , Xuan Y , Mu Y , Tang X , Ding X , Html Article Publication |
| oligosaccharides {oligosaccharides} - Rikenellaceae |
👪
The Protective Effects of 2`-Fucosyllactose against E. Coli O157 Infection Are Mediated by the Regulation of Gut Microbiota and the Inhibition of Pathogen Adhesion. Nutrients (Nutrients ) Vol: 12 Issue 5 Pages: Pub: 2020 May 1 Epub: 2020 May 1 Authors Wang Y , Zou Y , Wang J , Ma H , Zhang B , Wang S , Publication |
| oligosaccharides {oligosaccharides} - Rikenellaceae |
👪
Pectic oligosaccharides ameliorate high-fat diet-induced obesity and hepatic steatosis in association with modulating gut microbiota in mice. Food & function (Food Funct ) Vol: 14 Issue 21 Pages: 9892-9906 Pub: 2023 Oct 30 Epub: 2023 Oct 30 Authors Yu S , Wang H , Cui L , Wang J , Zhang Z , Wu Z , Lin X , He N , Zou Y , Li S , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
